홍정용 (성균관대학교 의과대학, 삼성서울병원)님 | 한빛사연구자 > 한빛사

Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years

J. Clin. Oncol., Jan 23 2026, | https://doi.org/10.1200/JCO-25-01169

2026-01
의약학
한빛사논문

Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients

Cancer Chemother. Pharmacol., Jan 2014, 73 (1) | https://doi.org/10.1007/s00280-013-2328-1

2014-01
의약학
상위피인용논문

Smoking Cessation and Pancreatic Cancer Risk in Individuals With Prediabetes and Diabetes: A Nationwide Cohort Study

J. Natl. Compr. Cancer Netw., Nov 2023, 21 (11) | https://doi.org/10.6004/jnccn.2023.7060

2023-11
의약학
한빛사논문

Reply to G. Wang et al. (Nonalcoholic Fatty Liver Disease May Be an Independent, Modifiable Risk Factor for Young-Onset Digestive Tract Cancers)

J. Clin. Oncol., 2023 Aug 21:JCO2301420| doi: 10.1200/JCO.23.01420

2023-08
의약학
한빛사논문

Increased Risk of Young-Onset Digestive Tract Cancers Among Young Adults Age 20-39 Years With Nonalcoholic Fatty Liver Disease: A Nationwide Cohort Study

J. Clin. Oncol., 2023 Apr 19;JCO2201740 | doi: 10.1200/JCO.22.01740

2023-04
의약학
한빛사논문

Association Between Smoking Cessation and the Risk of Cholangiocarcinoma and Ampulla of Vater Cancer: A Nationwide Cohort Study

Liver Cancer, Published online: February 09, 2023 | https://doi.org/10.1159/000529609

2023-02
의약학
한빛사논문

Threshold dose-response association between smoking pack-years and the risk of gallbladder cancer: A nationwide cohort study

Eur. J. Cancer, 2022 Dec 9;180:99-107 | https://doi.org/10.1016/j.ejca.2022.11.031

2022-12
의약학
한빛사논문

Association Between Glycemic Status and the Risk of Kidney Cancer in Men and Women: A Nationwide Cohort Study

Diabetes Care, 2022 Nov 9;dc220961 | https://doi.org/10.2337/dc22-0961

2022-11
의약학
한빛사논문

Light-to-Moderate Alcohol Consumption Increases the Risk of Biliary Tract Cancer in Prediabetes and Diabetes, but Not in Normoglycemic Status: A Nationwide Cohort Study

J. Clin. Oncol., Published online June 13, 2022 | DOI: 10.1200/JCO.22.00145

2022-06
의약학
한빛사논문

Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intratumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial

Genome Med., Published: 06 January 2022, 14, Article number: 1 | https://doi.org/10.1186/s13073-021-00995-8

2022-01
의약학
한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기